Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2CNS 2

Conditions

Sarcoma 4Sarcoma, Ewing 3Osteosarcoma 3Liposarcoma 3Rhabdomyosarcoma 2Rhabdoid Tumor 2Neuroblastoma 2Diffuse Intrinsic Pontine Glioma 2Breast Neoplasms 2Brain Neoplasms 2Triple Negative Breast Neoplasms 1Sarcoma, Kaposi 1Retinoblastoma 1Recurrence 1Pathologic Complete Response 1Neoplasms 1Neoplasm Metastasis 1Medulloblastoma 1Leiomyosarcoma 1Hemangiosarcoma 1Glioma 1Glioblastoma 1Ependymoma 1Colonic Neoplasms 1Chondrosarcoma 1Cholangiocarcinoma 1Acquired Immunodeficiency Syndrome 1

Interventions

Temozolomide 4Irinotecan 3abemaciclib 2Radiotherapy 2Cyclophosphamide 2Bevacizumab 2palbociclib 1dostarlimab 1dinutuximab 1adavosertib 1Vorinostat 1Vincristine 1Valproic Acid 1Topotecan 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiation 1Mebendazole 1Granulocyte-Macrophage Colony-Stimulating Factor 1Etoposide 1Eflornithine 1Carboplatin 1CLR1404 11-methyltryptophan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Diffuse Intrinsic Pontine Glioma × abemaciclib × Sarcoma × Clear all
NCT04238819 2026-03-02

A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma

Eli Lilly and Company

Phase 1/2 Completed
47 enrolled 36 charts
CNSSarcoma

Diffuse Intrinsic Pontine Glioma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma, Rhabdoid Tumor

NCT02644460 2023-10-26

AflacST1501

Emory University

Phase 1 Completed
53 enrolled
CNSSarcoma

Diffuse Intrinsic Pontine Glioma, Brain Neoplasms, Neuroblastoma, Recurrence, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡